Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
December 19, 2006
The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage
Lori S Hart, David Ornelles, Constantinos Koumenis
Cell
|
July 28, 2009
Cell death: a new Par-4 the TRAIL
Lori S Hart, Wafik S El-Deiry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2008
Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells
Lori S Hart, Wafik S El-Deiry
Cell Cycle (Georgetown, Tex.)
|
October 4, 2007
Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines
Raluca T Tavaluc, Lori S Hart, David T Dicker, et al.
Cancer Biology & Therapy
|
November 20, 2009
Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes
Joshua E Allen, Lori S Hart, David T Dicker, et al.
Carcinogenesis
|
May 18, 2006
Arachidonic acid-induced gene expression in colon cancer cells
Arta M Monjazeb, Kevin P High, Abbie Connoy, et al.
Cancer Biology & Therapy
|
September 21, 2007
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4
Robyn T Sussman, M Stacey Ricci, Lori S Hart, et al.
Science Translational Medicine
|
June 10, 2011
Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation
Nathan G Dolloff, Patrick A Mayes, Lori S Hart, et al.
The American Journal of Pathology
|
October 7, 2011
High-resolution imaging and antitumor effects of GFP(+) bone marrow-derived cells homing to syngeneic mouse colon tumors
Niklas K Finnberg, Lori S Hart, Nathan G Dolloff, et al.
Cell Cycle (Georgetown, Tex.)
|
July 2, 2011
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab
Lori S Hart, Nathan G Dolloff, David T Dicker, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
December 19, 2006
The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage
Lori S Hart, David Ornelles, Constantinos Koumenis
Cell
|
July 28, 2009
Cell death: a new Par-4 the TRAIL
Lori S Hart, Wafik S El-Deiry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2008
Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells
Lori S Hart, Wafik S El-Deiry
Cell Cycle (Georgetown, Tex.)
|
October 4, 2007
Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines
Raluca T Tavaluc, Lori S Hart, David T Dicker, et al.
Cancer Biology & Therapy
|
November 20, 2009
Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes
Joshua E Allen, Lori S Hart, David T Dicker, et al.
Carcinogenesis
|
May 18, 2006
Arachidonic acid-induced gene expression in colon cancer cells
Arta M Monjazeb, Kevin P High, Abbie Connoy, et al.
Cancer Biology & Therapy
|
September 21, 2007
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4
Robyn T Sussman, M Stacey Ricci, Lori S Hart, et al.
Science Translational Medicine
|
June 10, 2011
Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation
Nathan G Dolloff, Patrick A Mayes, Lori S Hart, et al.
The American Journal of Pathology
|
October 7, 2011
High-resolution imaging and antitumor effects of GFP(+) bone marrow-derived cells homing to syngeneic mouse colon tumors
Niklas K Finnberg, Lori S Hart, Nathan G Dolloff, et al.
Cell Cycle (Georgetown, Tex.)
|
July 2, 2011
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab
Lori S Hart, Nathan G Dolloff, David T Dicker, et al.
Page
of 3